- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05715203
Aortic Stiffness in Patients With Genetic Aortopathies (PULSEWAVE)
Aortic Stiffness in Patients With Genetic Aortopathies: Intervention Analysis
The goal of this observational study is to study arterial stiffness in patients with thoracic ascending aortic aneurysms (TAA), either syndromic or non-syndromic. The main questions it aims to answer are:
- Stratification of aortic risk based on arterial stiffness; Compare measurements with morphological and haemodynamic features of the ascending thoracic aorta.
Participants will be asked to undergo non-invasive evaluation of blood pressure and arterial stiffness.
Study Overview
Status
Intervention / Treatment
Detailed Description
Recent studies have highlighted the role played by the aorta and the great arteries in the regulation of the blood pressure (BP) and peripheral blood flow. Similarly, the structural and functional alteration of the aortic wall having a genetic cause is highly associated with the onset of aneurysms, especially of the ascending aorta, for which it is essential to monitor the aortic stiffness, which is detectable through a non-invasive and non-radioactive method such as Pulse Wave Velocity (PWV). Despite literature studies correlating PWV in MFS, few evaluations of aortic stiffness in patients with syndromic TAA have been done and its potential correlations with other aneurysm markers.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Alessandro Pini, MD
- Phone Number: +390252774705
- Email: alessandro.pini@grupposandonato.it
Study Locations
-
-
Lombardy
-
San Donato Milanese, Lombardy, Italy, 20097
- Recruiting
- IRCCS Policlinico San Donato
-
Contact:
- Alessandro Pini, MD
- Phone Number: +390252774705
- Email: alessandro.pini@grupposandonato.it
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Patients with ascending aortic aneurysms currently in follow.up at Cardiovascular Gentic Centre, IRCCS Policlinico San Donato.
Description
Inclusion Criteria:
- Subjects with AAT, either syndromic or non syndromic;
- Signed informed consent
Exclusion Criteria:
- Patients with early menopause and/or osteoporosis, rheumatic heart disease and active malignant tumours;
- Patients with acute and chronic inflammatory conditions such as: chronic liver disease, chronic renal insufficiency and diseases affecting the thyroid system;
- Seropositivity to HIV, HCV, HBsAg and SARS-CoV-2;
- Pregnancy
Study Plan
How is the study designed?
Design Details
- Observational Models: COHORT
- Time Perspectives: CROSS_SECTIONAL
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Syndromic TAA
Subjets with clinical or genetic diagnosis of syndromic thoracic aortic aneurysms |
Evaluation of arterial stiffness |
|
Non-syndromic TAA
Subjets without clinical or genetic diagnosis of syndromic thoracic aortic aneurysms |
Evaluation of arterial stiffness |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pulse Wave Velocity
Time Frame: 18 months
|
Statistic analysis will be performed using the Statistical Package for Social Science (SPSS for Windows; v20.0; SPSS, Chicago, Illinois, USA). Continuous variables will be expressed as mean ± Standard Deviation, while qualitative variables will be expressed as a percentage. Qualitative data will be compared using Fisher's test or Pearson's χ2 test, when appropriate. Continuous variables by t-test or analysis of variance normalized for covariates. Continuous variables will be correlated by simple or multiple linear regression |
18 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Alessandro Pini, Cardiovascular-Gentic Centre, IRCCS Policlinico San Donato
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Pulse Wave
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.